Target intelligence / Profile preview

Chaperone protein DnaK (DnaK)

Target
DnaK
Molecular classification
Enzyme, Chaperone, Heat shock protein
01

Overview

Chaperone protein DnaK is the primary bacterial representative of the Hsp70 family, serving as a central hub in the protein folding machinery (UniProt P0A6Y8). It facilitates the folding of newly synthesized proteins, prevents the aggregation of misfolded proteins, and assists in the translocation of proteins across membranes (PMID: 28836138). The functional cycle of DnaK is tightly regulated by its co-chaperones, DnaJ and GrpE, which modulate its ATP-bound and ADP-bound states to control substrate affinity (PMID: 31434151). In the context of infection, DnaK is crucial for bacterial survival under the stressful conditions of the host environment, such as high temperature and oxidative stress, and is often linked to the expression of virulence factors (PMID: 25613164). As a therapeutic target, DnaK is inhibited by various proline-rich antimicrobial peptides (PrAMPs) like apidaecin and oncocin, which bind to its substrate-binding pocket and stall the chaperone cycle (PMID: 21664394). This inhibition leads to the accumulation of misfolded proteins and eventual bacterial cell death, making it a high-priority target for addressing multi-drug resistant bacterial pathogens (PMID: 17506534).

Other names
70 kDa heat shock proteinHsp70 homologDnaK proteinHeat shock protein 70
02

Mechanism of action

Inhibition of the chaperone cycle by binding to the substrate-binding domain, preventing protein refolding and causing lethal protein aggregation (PMID: 21664394, 31434151).

03

Biological functions

Protein foldingStress responseProtein translocationPrevention of protein aggregation
04

Disease associations

Infection
05

Safety considerations

Cross-reactivity with human Hsp70Low bioavailability of peptide inhibitorsBacterial resistance
06

Interacting drugs

Apidaecin

5 more in the full profile.

07

Biomarkers

Bacterial protein aggregationDnaK expression levels

Beyond the preview

Go deeper on Chaperone protein DnaK (DnaK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chaperone protein DnaK (DnaK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call